CanSino’s inhaled COVID-19 vaccine gets emergency use approval in China
China’s CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been
China’s CanSino in talks for COVID vaccine Phase III trial overseas
Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia